Full text is available at the source.
Abstract
Hepatic circadian factor CLOCK may influence metabolic dysfunction-associated fatty liver disease (MAFLD) through its regulation of SREBP1.
- High-fat diet led to increased body weight and liver fat in male mice.
- CLOCK levels were significantly lower in the liver, disrupting lipid metabolism.
- The gene Srebf1, which encodes the transcription factor SREBP1, was up-regulated with lower CLOCK levels.
- In cellular models, reducing CLOCK increased SREBP1 and lipid accumulation, while over-expressing CLOCK had the opposite effect.
- In vivo, boosting CLOCK levels decreased liver triglycerides and cholesterol, reducing hepatic steatosis.
- SREBP1 signaling may be a key target of CLOCK in the development of MAFLD.
Simplified